enGene Holdings Inc. (ENGN) vs Spruce Biosciences, Inc. (SPRB)
A side-by-side comparison of enGene Holdings Inc. and Spruce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENGN
enGene Holdings Inc.
$1.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SPRB
Spruce Biosciences, Inc.
$42.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ENGN vs SPRB
growth of $100 · dividends reinvested · last 3yENGN -90.7% (-54.6%/yr)SPRB -45.9% (-18.5%/yr)SPRB compounded faster over this window
Log scale — wide-divergence pair
ENGN SPRB
ENGN vs SPRB: by the numbers
- •ENGN is the larger company ($121M vs $118M market cap).
Metrics side by side
Valuation
| Metric | ENGN | SPRB |
|---|---|---|
| P/B ratio | 0.52 | 1.41 |
Profitability
| Metric | ENGN | SPRB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -2.13% | -61.33% |
| ROIC | -1.78% | -50.67% |
Growth (annualized)
| Metric | ENGN | SPRB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -36.23% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.